| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5642461 | Oral Oncology | 2017 | 8 Pages |
Abstract
Detection of HR-HPV type-specific antibodies highly correlated with HPV-attributable OPSCC and was associated with better survival. HR-HPV antibodies are promising diagnostic, prognostic and potentially screening markers in HR-HPV-attributable OPSCC.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Martina A. Broglie, Wolfram Jochum, Angelika Michel, Tim Waterboer, Diana Foerbs, René Schoenegg, Sandro J. Stoeckli, Michael Pawlita, Dana Holzinger,